Gastroesophageal Reflux Disease Management

Initial Treatment

The American College of Gastroenterology recommends proton pump inhibitors (PPIs) as the first-line pharmacological treatment for gastroesophageal reflux disease (GERD), superior to H2 antagonists and placebo for both esophagitis healing and symptomatic relief 1
Initial treatment should start with omeprazole 20 mg or lansoprazole 30 mg once daily, taken 30-60 minutes before breakfast to optimally suppress acid production 1
For typical GERD symptoms without alarm signs, empirical treatment with PPIs is appropriate without initial endoscopy 1

The American Gastroenterological Association suggests that weight loss in overweight or obese patients has the strongest evidence of efficacy and should be recommended to all these patients, as it can prevent or delay the need for acid suppression 2, 1
Elevating the head of the bed by 6-8 inches (15-20 cm) can improve esophageal pH profiles for patients with nocturnal symptoms or regurgitation that disturbs sleep 1, 3
Avoiding lying down after eating can reduce esophageal acid exposure by 30-50% 1, 3

After 3 months of failed intensive medical therapy, objective diagnostic evaluation with endoscopy and/or 24-hour esophageal pH monitoring should be performed to document persistent GERD before considering surgery 2, 1
For extraesophageal symptoms that do not respond to PPIs, investigating non-GERD-related causes is recommended before proceeding with extensive functional tests, as these symptoms are less likely to resolve with PPI treatment 2

The American College of Surgeons recommends that laparoscopic antireflux surgery (fundoplication) should be considered for patients with objectively documented GERD who fail maximum medical therapy for at least 3 months 2, 1
The LOTUS RCT study showed that at 5 years, the remission rate was higher in the medication group than in the surgical group (92% vs 85%, p=0.048), although the difference was no longer significant after best-case scenario modeling of study dropouts 2

After initial symptom control, titration to the lowest effective dose of PPI that maintains symptomatic control is recommended 1
Periodic reevaluation of the need for continuous PPI therapy is necessary to minimize potential long-term risks 1
For confirmed erosive esophagitis or Barrett's esophagus, long-term PPI therapy is generally required, and benefits outweigh risks 4